Anzeige
❌
Mehr »
Freitag, 16.05.2025 - Börsentäglich über 12.000 News
Empire bei 89 Mio. USD - Doch dieser Titan-Explorer mit Drilltreffern notiert noch unter 6 Mio.?€!
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A2QKU8 | ISIN: US09076D1019 | Ticker-Symbol:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BIONOID PHARMA INC Chart 1 Jahr
5-Tage-Chart
BIONOID PHARMA INC 5-Tage-Chart

Aktuelle News zur BIONOID PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13:38Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation101ACCESS NewswireNEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformation...
► Artikel lesen
11.04.Bionoid Pharma, Inc.: Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit207ACCESS NewswireNEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for...
► Artikel lesen
09.04.Bionoid Pharma, Inc.: Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements220ACCESS NewswireNEW YORK, NY / ACCESS Newswire / April 9, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced it has engaged Aloba, Awomolo & Partners, a PCAOB-registered accounting firm, as its...
► Artikel lesen
19.03.Bionoid Pharma, Inc.: Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity251ACCESS NewswireNEW YORK, NY / ACCESS Newswire / March 19, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced that it has submitted an application to uplist from the OTC Pink to the OTCQB Venture...
► Artikel lesen
13.03.Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm226ACCESS NewswireNEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its financial audits for the fiscal years 2022...
► Artikel lesen
14.01.Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025213ACCESS NewswireNEW YORK CITY, NEW YORK / ACCESSWIRE / January 14, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The...
► Artikel lesen
BIONOID PHARMA Aktie jetzt für 0€ handeln
08.01.Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.226ACCESS NewswireNEW YORK, NY / ACCESSWIRE / January 8, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Letter...
► Artikel lesen
12.12.24Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.276ACCESS NewswireNEW YORK, NY / ACCESSWIRE / December 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the signing of a Binding Letter of Intent (LOI) with Vitawin Supplements Ltd....
► Artikel lesen
27.11.24Bionoid Pharma, Inc.: AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast286ACCESS NewswireNEW YORK, NY / ACCESSWIRE / November 27, 2024 / Bionoid Pharma (OTC PINK:BINP) unveils AI Maverick's game-changing sales automation in the latest episode of the BizUnLearned Podcast. Discover how this...
► Artikel lesen
26.11.24Bionoid Pharma, Inc.: The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time318ACCESS NewswireNEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) - Bionoid Pharma, Inc. ("Bionoid") ("BINP") (OTC Pink:BINP), the new owner of the AI Maverick platform...
► Artikel lesen
19.11.24Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion220ACCESS NewswireTORONTO, ON / ACCESSWIRE / November 19, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is excited to announce the incorporation of its wholly owned subsidiary, Enhanced Supplements Ltd., a critical...
► Artikel lesen
12.11.24Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.187ACCESS NewswireTORONTO, ON / ACCESSWIRE / November 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is excited to announce the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store...
► Artikel lesen
07.11.24Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit310ACCESS NewswireTORONTO, ON and NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is pleased to announce the formal engagement of Olayinka Oyebola & Co., a PCAOB-registered...
► Artikel lesen
05.11.24Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap234ACCESS NewswireAI-Driven Platform and Strategic Acquisitions to Drive Health & Wellness Growth and Profitability TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) has outlined...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1